AKT1 and endometrial carcinoma: One paper focusing on type I vs. type II endometrial carcinomas highlighted pathways such as p53, lysine degradation, cell cycle, and tight junction, while another paper analyzing endometrial carcinoma vs. normal adjacent mucosal tissue uncovered PI3K-AKT signaling, ECM-receptor interaction, and Focal adhesion [53,54].